Tech Company Financing Transactions

Genocea Biosciences Funding Round

Genocea Biosciences, based in Cambridge, received $35 million from Auriga Partners, Cycad Group and Johnson & Johnson Development Corporation.

Transaction Overview

Company Name
Genocea Biosciences
Announced On
1/3/2011
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors

Auriga Partners

Cycad Group

Johnson & Johnson Development Corporation (Dalton Einhorn)

Lux Capital (Robert Paull)

Morningside Group

Polaris Partners (Kevin Bitterman)

Skyline Ventures (Stephen Hoffman)

SR One Capital Management (Simeon George)

Proceeds Purpose
Proceeds will support Genocea as it enters clinical development for its lead program, a therapeutic vaccine for herpes simplex virus type 2 (HSV-2) infections. Genocea will also use funds to advance its deep research pipeline, including prophylactic vaccine programs addressing Chlamydia trachomatis, Streptococcus pneumoniae, HSV-2 and Plasmodium falciparum (malaria).

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Dr.
Cambridge, MA 02140
USA
Phone
(617) 876-8191
Website
www.genocea.com
Email Address
[email protected]
Overview
Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development.
Profile
Genocea Biosciences LinkedIn Company Profile
Social Media
Genocea Biosciences Company Twitter Account
Company News
Genocea Biosciences News
Facebook
Genocea Biosciences on Facebook
YouTube
Genocea Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chip Clark
  Chip Clark LinkedIn Profile  Chip Clark Twitter Account  Chip Clark News  Chip Clark on Facebook
Chief Financial Officer
Diantha Duvall
  Diantha Duvall LinkedIn Profile  Diantha Duvall Twitter Account  Diantha Duvall News  Diantha Duvall on Facebook
Chief Medical Officer
Thomas Davis
  Thomas Davis LinkedIn Profile  Thomas Davis Twitter Account  Thomas Davis News  Thomas Davis on Facebook
Chief Scientific Officer
Jessica Flechtner
  Jessica Flechtner LinkedIn Profile  Jessica Flechtner Twitter Account  Jessica Flechtner News  Jessica Flechtner on Facebook
VP - Bus. Development
Girish Aakalu
  Girish Aakalu LinkedIn Profile  Girish Aakalu Twitter Account  Girish Aakalu News  Girish Aakalu on Facebook
VP - Manufacturing
Narinder Singh
  Narinder Singh LinkedIn Profile  Narinder Singh Twitter Account  Narinder Singh News  Narinder Singh on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/3/2011: NanoHorizons venture capital transaction
Next: 1/4/2011: KnowledgeVision Systems venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.